$59.10
-2.95-4.75%
al cierre: Nov 11, 4:00 PM EST
$59.50
-2.55-4.11%
Premercado: 4:11 AM EST
10x Genomics (TXG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.15 | $-0.07 | -114.3 % |
| Q2 | Aug 6, 2026 | $-0.14 | $-0.06 | -133.3 % |
| Q1 | May 7, 2026 | $-0.10 | $-0.10 | 0.00 % |
| Q4 | Feb 12, 2026 | $-0.13 | $-0.10 | -30.0 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $150.67M | $147.72M | 2.00 % |
| Q2 | Aug 6, 2026 | $151.00M | $146.68M | 2.95 % |
| Q1 | May 7, 2026 | $150.84M | $146.38M | 3.05 % |
| Q4 | Feb 12, 2026 | $166.03M | $159.13M | 4.34 % |
10x Genomics (TXG) publicó su última previsión de noviembre 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $625M - $635M para el período.
En comparación con la previsión anterior, 10x Genomics elevado redujo su previsión de ingresos desde un rango anterior de $610M - $630M.
10x Genomics ha emitido 22 actualizaciones de orientación entre el febrero 15, 2023 y el noviembre 5, 2026. During this period, the company raised its outlook 13 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.07 | $-0.06 | $-0.10 | $-0.10 |
| Actual | $-0.15 | $-0.14 | $-0.10 | $-0.13 |
| Surprise | -114.3% | -133.3% | 0.00% | -30.0% |
| Revenue | ||||
| Estimate | $147.7M | $146.7M | $146.4M | $159.1M |
| Actual | $150.7M | $151.0M | $150.8M | $166.0M |
| Surprise | +2.00% | +2.95% | +3.05% | +4.34% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $-0.04 | $-0.12 | $-0.15 |
| Revenue | ||||
| Consensus | $178.1M | $167.5M | — | — |